PDGFRB and cancer: The presence of fibroblasts in the 3D cancer models provides the possibility of testing cancer drugs directed against the fibroblasts themselves, e.g. PDGFR-β and FAP-α that were both expressed in the 1BR.3.G fibroblast, are potential therapeutic targets in cancer (46).